Literature DB >> 21118382

A novel approach for assessments of erythrocyte sedimentation rate.

A Pribush1, L Hatskelzon, N Meyerstein.   

Abstract

INTRODUCTION: Previous studies have shown that the dispersed phase of sedimenting blood undergoes dramatic structural changes: Discrete red blood cell (RBC) aggregates formed shortly after a settling tube is filled with blood are combined into a continuous network followed by its collapse via the formation of plasma channels, and finally, the collapsed network is dispersed into individual fragments. Based on this scheme of structural transformation, a novel approach for assessments of erythrocyte sedimentation is suggested.
METHODS: Information about erythrocyte sedimentation is extracted from time records of the blood conductivity measured after a dispersion of RBC network into individual fragments.
RESULTS: It was found that the sedimentation velocity of RBC network fragments correlates positively with the intensity of attractive intercellular interactions, whereas no effect of hematocrit (Hct) was observed.
CONCLUSION: Thus, unlike Westergren erythrocyte sedimentation rate, sedimentation data obtained by the proposed method do not require correction for Hct.
© 2010 Blackwell Publishing Ltd.

Mesh:

Year:  2010        PMID: 21118382     DOI: 10.1111/j.1751-553X.2010.01277.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  3 in total

1.  Effects of Aggregation on Blood Sedimentation and Conductivity.

Authors:  Alexander Zhbanov; Sung Yang
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

2.  β-Dispersion of blood during sedimentation.

Authors:  Ahmet C Sabuncu; Sinan Muldur; Barbaros Cetin; O Berk Usta; Nadine Aubry
Journal:  Sci Rep       Date:  2021-01-29       Impact factor: 4.379

3.  Determination of erythrocyte sodium sensitivity in man.

Authors:  Hans Oberleithner; Marianne Wilhelmi
Journal:  Pflugers Arch       Date:  2013-05-19       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.